Stuart A. Arbuckle - 18 Jun 2025 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Director
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Stuart A. Arbuckle
Issuer symbol
RYTM
Transactions as of
18 Jun 2025
Net transactions value
$0
Form type
4
Filing time
23 Jun 2025, 16:51:08 UTC
Previous filing
15 May 2025
Next filing
26 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Arbuckle Stuart A Director 222 BERKELEY STREET, 12TH FLOOR, BOSTON /s/ Stephen Vander Stoep, attorney-in-fact for Stuart A. Arbuckle 23 Jun 2025 0001557290

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +4,000 +133% 7,000 18 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -4,000 -100% $0.000000 0 18 Jun 2025 Common Stock 4,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date.